Navigation Links
BchiVac V-1000 vacuum pump, 120V

ProductsBchiVac V-1000 vacuum pump, 120V
Company Brinkmann
Item BchiVac V-1000 vacuum pump, 120V
Features Inquire
Description Model V-1000 is a new addition to the powerful PTFE membrane vacuum pump line from Bchi. This high performance pump can achieve an ultimate vacuum of 1 mbar or a flow rate of 64 L/min.

Applications

  • For use with vacuum drying ovens and centrifugal vacuum concentrators
  • Distillation applications from lab size up to industrial size rotary evaporators BchiVac V-1000 product features
BchiVac V-1000 product features
  • Serial hose attachment supplies low ultimate vacuum of 1 mbar
  • Parallel hose attachment supplies high flow rate of 64 L/min
  • Integrated switchbox turns pump on and off as requiredreduces noise levels and extends the lifetime operation of the pump
  • Modular design allows use with Vacuum Controller V-800 and/or water-cooled secondary condenser to provide precise vacuum regulation with solvent vapor collection

Additional product features with Pump Controller V-719

  • Automatic changeover from parallel (64 L/min) to serial (1 mbar); quickly and easily achieves ultimate vacuum of 1 mbar
  • Unit can be used as a central vacuum source for the entire lab; no control cables are required from each apparatus, as unit maintains low ultimate vacuum; turns on only when additional vacuum is needed
  • Each separate rotary evaporator, gel dryer, vacuum oven, etc., can run at different vacuum pressures with individual controllers or shut-off valves
Info Brinkmann
Customer Service: (800) 645-3050
Web site: http://www.brinkmann.com

Related medicine products :

1. BchiVac V-500 vacuum pump, 110 V
2. BchiVac V-500 vacuum pump, 230 V
3. BchiVac V-1000 vacuum pump, w/Pump Controller V-719, and automatic change over valve
4. CSV-1000HGT with 1 Test Face
5. CSV-1000HGT with 2 Test Face
6. BV-1000 automated subjective refraction system
7. CSV-1000 Instrument
8. Vacuum pump, 220 V
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
Medicine Products:
(Date:8/29/2008)...Attorneys representing consumers in a,case accusin...price of,virtually every prescription drug have cr...paring for a trial set for December 1 in U.S. Dist....com/cgi-bin/prnh/20080317/AQM144LOGO ), Attorney...of,third-party payers and consumers, claiming that...
(Date:8/29/2008)...SNewswire/ -- The following is a,statement by Matt... Kids:, For the second time in a month, Philip Mo... and promotion of a concert in a developing countr...ngaging in cigarette,marketing that appeals to chi...s been forced to withdraw from,an August 30 reunio...
(Date:8/29/2008)...re/ -- In response to recent news,about Michigan,s...(CWD),members of the deer farming community have ...son fast approaching, the tragic incident regardin...farm understandably has,created concern among hunt...he great state of Michigan. The deer farming indus...
(Date:8/29/2008)... published in the August 28 issue of the New Engl...ate administered to women delivering before 32 wee... by 50 percent. The Beneficial Effects of Antenata...18 centers in the U.S., including Northwestern Mem... found to reduce the instance of cerebral palsy re...
Breaking Medicine News(10 mins):Health News:Hagens Berman Sobol Shapiro: Attorneys Representing Consumers Prepare for $12 Billion RICO Trial Against McKesson for Alleged Drug Price Manipulation 2Health News:Hagens Berman Sobol Shapiro: Attorneys Representing Consumers Prepare for $12 Billion RICO Trial Against McKesson for Alleged Drug Price Manipulation 3Health News:Philip Morris International Forced to Drop Another Concert Sponsorship; Philippines Health Department Applauded for Taking Action 2Health News:Deer Farm Industry in Michigan Issues Statement on the Recent Chronic Wasting Disease Case Identified on a Kent County Deer Farm 2Health News:National study shows magensium sulfate reduces risk of cerebral palsy in premature births 2
...roved for treatment to breast cancer patients with...ith breast cancer// produce this Her-2 protein in ...ggressive and resist chemotherapy and Tamoxifen th...in is a humanized monoclonal antibody prepared for...
...ired by teenagers in Scotland who wish to get tatt... studios will also be subject to mandatory licensi...e hygiene. This is applicable to all those who are... behind the exercise is to reduce the possibilitie...
...anies which are proved to be better than older dru...tual benefit of these drugs could be realized repo...rder). MSF (Medicine sans Frontiers) have accused...elling their new drugs in Africa. MSF is providing...
...measles outbreaks in the quake-hit Pakistan as the...ting temperatures//. Pakistan-administered Kashmir...gainst the disease, with nearly 200,000 under-five...ll. An extra dose of oral polio vaccine was also a...
Other Medicine News:
(Date:8/26/2008).../- XTENT, Inc.,(Nasdaq: XT...llow-up data,from the CUSTOM II trial was publishe...urnal, EuroIntervention. The lead author of the ar...y Medical Center Utrecht, Utrecht,The Netherlands...clinical,sites across Europe., The one-year CUSTO...
(Date:8/25/2008)...d in Menstrual Blood May Offer Long-Lasting ..., OLDSMAR, Fla., Aug. 25 /- Time. It...ee that there never seems to be enough,of it. And ...omething just,for herself usually pales in compari...y has led many women in need of quality time to se...
(Date:8/25/2008)...calls it a ,miracle, LATHAM, N.Y., Aug. 25 /PRNe...ded Radiation Therapy program at Community Care Ph...patients using RapidArc(TM),radiotherapy technolog...vancement that delivers a highly-precise image-gui...ment in two minutes or less., RapidArc treatments...
(Date:8/22/2008)...l Sponsored by Medical Research Council, LEXINGTO...s,Pharmaceuticals, Inc. (Nasdaq: IDEV ) announced...P 301, a Phase III clinical trial of PRO 2000, the...revention of HIV and other,sexually transmitted in...gdom,s Medical Research Council (MRC) and conducte...
Breaking Medicine Technology:XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention 2XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention 3XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention 4Going Beyond 'Spa Day': Giving Women the Opportunity to Do Something Proactive Which May Lead to Long Term Health Benefits 2Image Guided Radiation Therapy in Latham, NY. Now Fighting Cancer Using Fast and Precise RapidArc(TM) Radiotherapy Technology 2Image Guided Radiation Therapy in Latham, NY. Now Fighting Cancer Using Fast and Precise RapidArc(TM) Radiotherapy Technology 3Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000 2Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000 3Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000 4Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000 5Trust for Americas Health 3A New E Coli Outbreak Confusion Around Salmonella Show Food Safety System Remains Broken 23204 1Trust for Americas Health 3A New E Coli Outbreak Confusion Around Salmonella Show Food Safety System Remains Broken 23204 2Boston Scientific Announces FDA Approval for PROMUS 28TM 29 Everolimus Eluting Coronary Stent System 6366 1Boston Scientific Announces FDA Approval for PROMUS 28TM 29 Everolimus Eluting Coronary Stent System 6366 2Boston Scientific Announces FDA Approval for PROMUS 28TM 29 Everolimus Eluting Coronary Stent System 6366 3Boston Scientific Announces FDA Approval for PROMUS 28TM 29 Everolimus Eluting Coronary Stent System 6366 4Search for salt tolerant grasses aims to improve roadside plantings 3881 1Search for salt tolerant grasses aims to improve roadside plantings 3881 2New Drug Slows Thyroid Cancer 23202 1New Drug Slows Thyroid Cancer 23202 2
...mproved Potential to,Battle Their Disease, PASADEN...herapeutics, Inc., a majority-owned subsidiary of ... novel delivery system,called Cyclosert(TM) will b...erican Association for Cancer Research (AACR) Annu...w research findings,on a promising anticancer ther...
...Novelos,Therapeutics, Inc. (OTCBB: NVLT), a biopha...therapeutics to treat cancer and,hepatitis, today ...Dr. Kenneth Tew and Dr. Danyelle Townsend of the M...ing two poster presentations at the,ongoing Americ...,These presentations will highlight in vivo and in...
Other Medicine Technology:Poster on Cyclosert Drug Delivery Presented at AACR Meeting 2Poster on Cyclosert Drug Delivery Presented at AACR Meeting 3Poster on Cyclosert Drug Delivery Presented at AACR Meeting 4Novelos Therapeutics and MUSC Present Two Posters at AACR 2007,Annual Meeting 2